Response to “High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma”

  1. Vega, F.M.
  2. Colmenero-Repiso, A.
  3. Gómez-Muñoz, M.A.
  4. Rodríguez-Prieto, I.
  5. Aguilar-Morante, D.
  6. Ramírez, G.
  7. Márquez, C.
  8. Cabello, R.
  9. Pardal, R.
Revue:
EBioMedicine

ISSN: 2352-3964

Année de publication: 2020

Volumen: 53

Type: Note

DOI: 10.1016/J.EBIOM.2020.102703 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable